J&J Slammed With $482M Verdict In Stent Patent Suit
A federal jury hit Johnson & Johnson with a $482 million verdict on Friday, finding that the company's popular Cypher coronary stent infringes a patent held by a New Jersey radiologist....To view the full article, register now.
Already a subscriber? Click here to view full article